Novel dopamine autoreceptor agonists B-HT 920 and DMD 49980 in the treatment of 
patients with schizophrenia

Wiedemann, K.; Krieg, J.-C.; Loycke, A.; Holsboer, F.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Book Chapter

Novel dopamine autoreceptor agonists B-HT 920 and DMD 49980 in the treatment of patients with schizophrenia

MPS-Authors

/persons/resource/persons80372

Holsboer, F.
Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Wiedemann, K., Krieg, J.-C., Loycke, A., & Holsboer, F. (1992). Novel dopamine autoreceptor agonists B-HT 920 and DMD 49980 in the treatment of patients with schizophrenia. In H. Y. Meltzer (Ed.), Novel Antipsychotic Drugs (pp. 91-98). New York: Raven Press.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-8727-9

Abstract

There is no abstract available